CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
4 research outputs found
Phase II trial of atezolizumab before and after definitive chemoradiation for unresectable stage III NSCLC.
Author
Carter Dufrane
David E. Kozono
+10 more
Everett E. Vokes
Helen J. Ross
Ilze Bara
James John Urbanic
Jane Michelle Brockman
Katja Schulze
Mayank Gandhi
Terence Marques Williams
Tom Stinchcombe
Xiaofei F. Wang
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
Field of study
No full text
Crossref
ALEXANDRA/IMpassion030:A phase III study of standard adjuvant chemotherapy with or without atezolizumab in early-stage triple-negative breast cancer.
Author
Anh Nguyen Duc
Bailey Andrew
+18 more
Bouhlel Aicha
Brandao Mariana
Daly Fergus
Dufrane Carter
Freeman Christie
Fumagalli Debora
Gelber Richard D.
Guillaume Sebastian
Honvault Vanessa
Ignatiadis Michail
Karusinova Valeria
Lai Catherine
Luis Martinez Jorge
McArthur Heather L.
Metzger Otto
Piccart Martine J.
Viale Giuseppe
Winer Eric S.
Publication venue
'American Society of Clinical Oncology (ASCO)'
Publication date
20/05/2019
Field of study
No full text
University of St. Andrews - Pure
Improved Islet Purity by the Hypertonic-Hypotonic Method
Author
Bretzel R.G.
Carter J.D.
+21 more
Dellè H.
Deters N.A.
Dufrane D.
Eckhard M.
Elsanhoty R.M.
Fiorina P.
Guillam M.T.
Hani H.
Ichii H.
Job J.
Kopska T.
Langlois G.
Liu C.
Ma Y.
McCall M.D.
Qiao A.Y.
Ricordi C.
Ricordi C.
Shimoda M.
Wang W.
Zhang X.L.
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref